GLP-1 receptor agonists reduce glucagon and glycogen secretion, inhibit appetite and slow gastric emptying [17] [18], creating a multifaceted approach to weight management that addresses both metabolic and behavioral components of obesity
The ultra-processed food supply, office work, commuting, technological access, and environmental toxins all promote excess body fat
Nausea, vomiting, diarrhea, abdominal pain, and constipation occur frequently with both formulations, typically emerging during dose escalation and often diminishing over time as patients develop tolerance
Peak is injections only
Temperature excursions are the silent killer
Why Choose ZYP Medical for TRT and Weight Loss